CD8A and neoplasm: Corresponding to these results, enhanced memory CD4+ and CD8+ T cells in tumor infiltrating lymphocytes (TILs), peripheral blood and spleen were observed in the tumor-bearing mice receiving high-dose and low-frequency αPD-L1 treatment (Fig. 4c, d, and Supplementary Fig. 4a).